MYOFORMIN
Pharmaceutical preparations for the treatment of of skeletal muscle atrophy, sarcopenia, cachexia, muscular weakness, fatigue, obesity, diabetes, oncological disorders, hematological disorders, cancer, conditions associated with aging, heart failure, COPD, end stage renal failure, cirrhosis, critical illness, spinal cord injury, stroke, Parkinson’s disease, Alzheimer’s disease, rheumatoid arthritis, autoimmune disorders, Cushing’s syndrome, hypogonadism, osteoarthritis, orthopedic injur...
Pending · March 19, 2025 · 99092562 ·